OR43 Steroid Hormone Receptors and Coregulators: Involvement in Cross-Talk and Signaling

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Nuclear Receptors and Steroid Hormone Action-Basic/Translational
Monday, April 4, 2016: 10:00 AM-11:30 AM
Room 104 (BCEC)
Chairs:
Patricia Virginia Elizalde, Ph.D., IBYME - CONICET, Buenos Aires, Argentina and Bandana Chatterjee, BSC, MS, PHD, Univ of TX Hlth Sci Ctr, San Antonio, TX

Nothing to Disclose: PVE, BC Disclosure Not Provided: KAB, DPE, DMR
10:00 AM
Yewei Xing, PhD, Internal Medicine, University of Michigan, Ann Arbor, MI and Gary D Hammer, MD, PhD, Metabolism, Diabetes, & Endocrinology, Dept. of Internal Medicine, Dept. of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI
10:15 AM
Sangeeta Kumari1, Simon Schlanger1, Dan Wang2, Song Liu2 and Hannelore Heemers, PhD3, (1)Cleveland Clinic
(2)Roswell Park Cancer Institute
(3)Lerner Research Institute, Cleveland Clinic, Cleveland, OH
10:30 AM
Sulgi Park, MS1, Chung Seog Song, PHD1, Shoulei Jiang, PHD1, Zhihua Zhang, MD, PHD1, Jodie Cropper, BA1 and Bandana Chatterjee, BSC, MS, PHD2, (1)Molecular Medicine, Univ of Texas Hlth Science Ctr, San Antonio, TX
(2)Dept of Moleular Medicine, Univ of TX Hlth Sci Ctr, San Antonio, TX
10:45 AM
Sornsawan Kawprasertsri, Graduate Program in Clinical Biochemistry and Molecular Medicine, Clincal Chemistry Department, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand, Richard J Pietras, M.D., Ph.D., Department of Medicine, Division of Hematology-Oncology, UCLA David Geffen School of Medicine and Jonsson Comprehensive Cancer Center, Los Angeles, CA, Diana Carolina Marquez-Garban, Ph.D., Department of Medicine, Division of Hematology-Oncology, UCLA David Geffen School of Medicine, Los Angeles, CA, Dean P Edwards, Ph.D., Department of Molecular and Cellular Biology; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX and Viroj Boonyaratanakornkit, Ph.D., Graduate Program in Clinical Biochemistry and Molecular Medicine, Clinical Chemistry Department, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand
11:00 AM
Hillary L Adams, M.S.1, James K. Pru2, John J Peluso3 and Sandra L Petersen, PhD1, (1)Veterinary and Animal Sciences, University of Massachusetts Amherst, Amherst, MA
(2)Washington State University, Pullman, WA
(3)Cell Biology, UConn Health, Farmington, CT
11:15 AM
Mara Livezey1, Chengjian Mao2, Ji Eun Kim2 and David J Shapiro, PhD3, (1)Biochemistry, University of Illinois Urbana Champaign, Urbana, IL
(2)Biochemistry, University of Illinois
(3)Dept of Biochemistry, University of Illinois, Urbana, IL

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire